<ѻý>Opinion Makers: Jury Still Out on Gene-Guided DLBCL Therapyѻý> Rationale for subtyping, but treatment data inconclusive Mar 02, 2016 video
<ѻý>Friday Feedback: How Safe Is Vaginal Estrogen for Breast Cancer Survivors?ѻý> ACOG endorsed its use, but what do experts think? Feb 26, 2016
<ѻý>Calling a Doctor by His or Her First Nameѻý> It's different without a longstanding relationship, says James C. Salwitz, MD Feb 23, 2016
<ѻý>ACOG: Vaginal Estrogen Safe for Breast Ca Survivorsѻý> No increased risk of cancer recurrence Feb 23, 2016
<ѻý>Colonoscopy Complications Occur at Surprisingly High Rateѻý> Approaching 2% within a week of 'scoping Feb 16, 2016
<ѻý>Medical Schools Boost Pain Management Educationѻý> In light of opioid epidemic, more schools focus on thoughtful prescribing Feb 04, 2016
<ѻý>Shorter Therapy an Option for High-Risk Anal Cancerѻý> Abbrieviated chemoradiation matches standard with less toxicity Jan 24, 2016
<ѻý>Dedicating a Career to Diversity and Disparitiesѻý> NMA president Edith Mitchell, MD, laments racial gaps in medicine Jan 21, 2016
<ѻý>No DFS Benefit With Chemoradiation in Bladder Cancerѻý> Adjuvant combo reduces local recurrence after cystectomy Jan 13, 2016
<ѻý>Adding Hormonal Tx To Salvage RT Ups Prostate Ca Survivalѻý> Metastasis, cancer-specific survival also reduced in high-risk disease Jan 11, 2016
<ѻý>Lower-Dose RT New Standard for Prostate Cancer?ѻý> Non-inferiority demonstrated for 60 Gy versus 74 Gy Jan 09, 2016
<ѻý>Aspirin May Lower Risk of Lethal Prostate Cancerѻý> But confirmation needed before a firm recommendation can be made Jan 05, 2016
<ѻý>SEER Data Errors: NCI Looks To Avoid Repeatsѻý> Results reassuring as SEER audit nears completion Dec 23, 2015
<ѻý>Slippery Slope: A Targeted Therapy That Misses the Mark?ѻý> Afinitor racks up FDA approvals, but where is the evidence? Dec 13, 2015
<ѻý>Rheumatoid Factor Tied to Sjogren's Lymphomaѻý> Disease activity also contributed to blood cancer risk in Sjogren's syndrome Dec 02, 2015
<ѻý>Is SAMHSA to Blame for a Broken Mental Health System?ѻý> Two members of Congress differ on how to fix a failing system Oct 09, 2015
<ѻý>'Failure to Communicate' Drives Misdiagnosisѻý> Electronic medical records also need to be improved, says Mark Graber, MD Oct 05, 2015
<ѻý>Teach Patients How to Communicate Symptoms Betterѻý> Patients should learn the eight characteristics of a symptom Oct 01, 2015
<ѻý>Doctors Urged to Practice 'Conservative Diagnosis'ѻý> And sharing cell phone numbers is a good idea Sep 29, 2015
<ѻý>Post-Op CT Scans May Improve Lung Cancer Survivalѻý> 4-year survival rate up 12 percentage points in patients having scans Sep 28, 2015
<ѻý>'Too Toxic' Colorectal Cancer Drug Now OK'dѻý> FDA approves tipiracil-trifluridine combo, to be sold as Lonsurf Sep 22, 2015
<ѻý>Patient Registries See Promise and Challenges Aheadѻý> Physician-driven registries adapt to a changing health system Sep 11, 2015
<ѻý>Hybrid Academic-Community Cancer Centers Take Shapeѻý> Emerging model takes cutting-edge oncology into the community Aug 31, 2015
<ѻý>Clear Health Costs: Having Insurance Doesn't Always Payѻý> The case of the $1,700 mammogram Aug 26, 2015
<ѻý>Giving Patients Evidence-Based Reassuranceѻý> In response to the Less-is-More series, here are five evidence-based tips for reassuring patients Aug 07, 2015
<ѻý>FDA Approves Drug for Basal Cell Carcinomaѻý> Sonidegib becomes second hedgehog inhibitor for locally advanced disease. Jul 24, 2015
<ѻý>Susan G. Komen Founder Steps Out of Spotlightѻý> Nancy Brinker says she won't forget her "promise" to the breast cancer community Jun 29, 2015
<ѻý>Viagra and Melanoma: Is There a Link?ѻý> Perry Wilson, MD, gives his take on Viagra, Cialis, and skin cancer Jun 24, 2015 video
<ѻý>One Proteasome Inhibitor Tops Another in Relapsed Myelomaѻý> Progression-free survival doubled with carfilzomib versus bortezomib Jun 15, 2015
<ѻý>PFS Rises in Progressive Myeloma with Targeted Biologicѻý> Adding elotuzumab boosts median progression-free survival by almost 5 months. Jun 12, 2015
<ѻý>Bone Drugs Equal as Breast Cancer Therapiesѻý> Little difference seen among bisphosphonates as cancer fighters. Jun 02, 2015
<ѻý>How ASCO'S First Clinical Trial -- TAPUR -- Came To Beѻý> ASCO's entry will evaluate off-label use of targeted agents Jun 02, 2015
<ѻý>ASCO: Gazyva Doubles Average Remission Time in NHLѻý> Obinutuzumab delays progression in rituximab-refractory indolent disease. May 31, 2015 video
<ѻý>Ibrance Delivers in Advanced Breast Caѻý> Palbociclib-fulvestrant combo leads to better PFS as second-line therapy May 31, 2015 video
<ѻý>ASCO: Annual Meeting Emphasizes Advances, Challenges in Cancerѻý> Largest program to date highlights developments in breast cancer, other malignancies May 29, 2015
<ѻý>ASCO: Chemo-ADT Combo Still Winning in Prostate Cancerѻý> Yet another report of survival improvement with upfront docetaxel plus hormonal therapy. May 14, 2015
<ѻý>Antitibiotic-Chemo Combo Cuts Infection Risk in AMLѻý> Incidence of Streptococcus viridans more than halved with prophylaxis. May 10, 2015
<ѻý>Injecting Opioid Tied to Blood Clotting Disorderѻý> Are most clinicians aware of this side effect of oxymorphone drug abuse? May 10, 2015
<ѻý>ACP Prefers Cervical Cytology Over DNA Screens for Young Womenѻý> HPV testing in women under 30 could cause more harm than good, group says. Apr 30, 2015